Depressive Symptoms among Older Adults with Rheumatoid Arthritis during the COVID-19 Pandemic: A Repeated Cross-sectional Study
Abstract
Background To compare the prevalence of depressive symptoms among older adults with and without rheumatoid arthritis (RA) in 2019 and 2022 using large-scale population-based data.Methods This repeated cross-sectional study used data from the Japan Gerontological Evaluation Study 2019 and 2022. A questionnaire was mailed to community-dwelling adults aged ≥65 years, identifying patients with RA undergoing treatment using self-reported information. Depressive symptoms were defined as a Geriatric Depression Scale (GDS) score ≥5. Multivariable logistic regression included an interaction term (RA × survey year) to assess whether the association between RA and depressive symptoms differed by year, adjusting for sociodemographic, health, and lifestyle factors.Results The number of participants with and without RA were 433 and 16,958 in 2019 and 472 and 16,881 in 2022 (total: 34,744). From 2019 to 2022, depressive symptoms increased among those with RA (35.5% to 40.4%), but changed minimally among those without RA (25.6% to 26.2%). The RA × year interaction was positive (OR 1.37, 95% CI 1.02-1.83; P = 0.036), indicating a greater increase in depressive symptoms among older adults with RA than among non-RA peers. Exploratory stratified analyses showed significant RA-by-year interactions among participants aged ≥75 years, those living alone or unmarried, those with lower educational attainment, never-smokers, and urban residents.Conclusions The difference in depressive symptoms between older adults with and without RA was greater in 2022 than that in 2019. Public health and clinical strategies that incorporate mental health and social support should be considered for vulnerable older adults with RA.
Related
- Differences in associations between coping styles and depressive symptoms across pandemic-related periods among university students with subthreshold depressive symptoms: a serial cross-sectional study.
- Association between PHQ-9-measured depressive symptoms and a positive AD8 screen among older adults during the COVID-19 pandemic: a large cross-sectional study in China
- Pulmonary Manifestations in Patients With Rheumatoid Arthritis Presenting With Respiratory Symptoms at a Tertiary Care Center in Central India: A Cross-Sectional Study.
- Associations of pandemic-era telework with cognition and depressive symptoms among middle-aged and older nonagricultural workers in China: a longitudinal CHARLS study
- Moderating effect of social support on the association between changes in financial stress and depressive and anxiety symptoms during the COVID-19 pandemic in Medicaid recipients: a longitudinal study
BibTeX
@article{yukishima2026depressive,
title = {{Depressive Symptoms among Older Adults with Rheumatoid Arthritis during the COVID-19 Pandemic: A Repeated Cross-sectional Study}},
author = {Toshitaka Yukishima and Taiji Noguchi and Yusuke Okubo and Shogo Furukawa and Yosuke Shibata and Tomoya Myojin and Masayo Kojima and Kumiko Shimoyama and Yuichiro Maekawa and Katsunori Kondo and Toshiyuki Ojima},
journal = {Internal Medicine},
year = {2026},
month = sep,
doi = {10.2169/internalmedicine.7925-26},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7925-26/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Depressive Symptoms among Older Adults with Rheumatoid Arthritis during the COVID-19 Pandemic: A Repeated Cross-sectional Study
AU - Toshitaka Yukishima
AU - Taiji Noguchi
AU - Yusuke Okubo
AU - Shogo Furukawa
AU - Yosuke Shibata
AU - Tomoya Myojin
AU - Masayo Kojima
AU - Kumiko Shimoyama
AU - Yuichiro Maekawa
AU - Katsunori Kondo
AU - Toshiyuki Ojima
PY - 2026
DA - 2026/09/29
JO - Internal Medicine
DO - 10.2169/internalmedicine.7925-26
UR - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7925-26/_article
AB - Background To compare the prevalence of depressive symptoms among older adults with and without rheumatoid arthritis (RA) in 2019 and 2022 using large-scale population-based data.Methods This repeated cross-sectional study used data from the Japan Gerontological Evaluation Study 2019 and 2022. A questionnaire was mailed to community-dwelling adults aged ≥65 years, identifying patients with RA undergoing treatment using self-reported information. Depressive symptoms were defined as a Geriatric Depression Scale (GDS) score ≥5. Multivariable logistic regression included an interaction term (RA × survey year) to assess whether the association between RA and depressive symptoms differed by year, adjusting for sociodemographic, health, and lifestyle factors.Results The number of participants with and without RA were 433 and 16,958 in 2019 and 472 and 16,881 in 2022 (total: 34,744). From 2019 to 2022, depressive symptoms increased among those with RA (35.5% to 40.4%), but changed minimally among those without RA (25.6% to 26.2%). The RA × year interaction was positive (OR 1.37, 95% CI 1.02-1.83; P = 0.036), indicating a greater increase in depressive symptoms among older adults with RA than among non-RA peers. Exploratory stratified analyses showed significant RA-by-year interactions among participants aged ≥75 years, those living alone or unmarried, those with lower educational attainment, never-smokers, and urban residents.Conclusions The difference in depressive symptoms between older adults with and without RA was greater in 2022 than that in 2019. Public health and clinical strategies that incorporate mental health and social support should be considered for vulnerable older adults with RA.
SN - 1349-7235
SN - 0918-2918
ER -